Increased osteoprotegerin levels in women with previous gestational diabetes developing metabolic syndrome.

AKINCI B., ÇELTİK A., Yuksel F., Genc S., Yener S., SEÇİL M., ...More

Diabetes research and clinical practice, vol.91, no.1, pp.26-31, 2011 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 91 Issue: 1
  • Publication Date: 2011
  • Doi Number: 10.1016/j.diabres.2010.09.028
  • Journal Name: Diabetes research and clinical practice
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.26-31
  • Keywords: Cardiovascular risk, Metabolic syndrome, OPG, Previous gestational diabetes
  • Dokuz Eylül University Affiliated: Yes

Abstract

Osteoprotegerin (OPG), a novel soluble member of tumour necrosis factor receptor superfamily, has been shown to link cardiovascular disorders. The aim of this study is to investigate the potential relationship between serum OPG levels, cardiovascular risk factors and metabolic syndrome in a relatively large group of women with previous GDM.